New cancer drug shows promise in early trial

NCT ID NCT05858164

Completed Disease control Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This early-phase study tested a new drug called BAY 2862789 in 45 people with advanced solid tumors, including non-small cell lung cancer. The drug works by activating immune cells to fight cancer. The main goals were to check safety, find the best dose, and see how the drug moves through the body. Participants took the drug until their cancer worsened or side effects became too severe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMORS NON-SMALL CELL LUNG CANCER

Contacts and locations

Locations

AdventHealth medical Group Oncology Research at Celebration

Celebration, Florida, 34747, United States
Asan Medical Center | Oncology

Seoul, 05505, South Korea
Brigette Harris Cancer Pavilion at Henry Ford Cancer Center - Detroit

Detroit, Michigan, 48202, United States
Chungbuk National University Hospital | Hematology and Oncology

Chungcheongbuk-do, North Chungcheong, 28644, South Korea
Gyeongsang National University Hospital | Oncology

Jinju, Gyeongsangnam-do, 52727, South Korea
Hadassah Hebrew University Hospital Ein Kerem

Jerusalem, 9112001, Israel
Hospital Universitari Vall D Hebron | Oncologia

Barcelona, 08035, Spain
Hospital Universitario Virgen De La Victoria | Oncologia

Málaga, 29010, Spain
Jilin Cancer Hospital

Changchun, Jilin, 130000, China
Princess Alexandra Hospital Australia

Woolloongabba, Queensland, 4102, Australia
START | San Antonio

San Antonio, Texas, 78229, United States
Seoul National University Hospital | Oncology

Jongno -Gu, Seoul, 03080, South Korea
Seoul St Mary's Hospital | Oncology

Seoul, 06591, South Korea
Tel- Aviv Sourasky Medical Center - Nephrology

Tel Aviv, 6423906, Israel
The Kinghorn Cancer Centre - Medical Oncology Department

Darlinghurst, New South Wales, 2010, Australia
Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech.

Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.